The VerifyNow System assesses patient's platelet reactivity to antiplatelet medications
Up to 33% of patients on antiplatelet medications may not reach the expected platelet inhibiting effect
VerifyNOW este primul sistem precis si rapid de monitorizare a raspunsului pacientului la inhibitori de P2Y12.
Este un echipament usor de utilizat destinat medicilor pentru adaptarea tratamentului fiecarui pacient.
Uses two types of tests depending on the used antiplatelet medication:
VerifyNow Aspirin Test::
- Measures the patient response to aspirin
- Quantitative results measured in ARU (Aspirin Reaction Units)
- Range: 350-700 ARU
- Cut-off value: 550 ARU
VerifyNow PRUTest::
- Measures the patient platelet response to P2Y12 inhibitors (clopidogrel, prasugrel and ticagrelor)
- Quantitative results measured in PRU (P2Y12 Reaction Units) and inhibition percentage (%)
- Range: 95-208 PRU